Login
Home
Charts
Search
Watchlist
Products

Pharmaids Pharmaceuticals Ltd

PHARMAID·BSE
₹30.78+3.85%Wed, 23 Sept '26 15:19
Industry:Pharma - Formulators
Indices:

Pharmaids Pharmaceuticals Ltd

PHARMAID
BSE
₹30.78
+3.85%
|Wed, 23 Sept '26 15:19
SOICxStockScans Reports
Industry
Pharma - Formulators
Indices
View
Financials
Documents
Shareholdings
Corporate Actions
Segments
Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Peer Comparison
Financials
Documents
Shareholdings
Corporate Actions
Segments
Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Peer Comparison
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹109Cr
Close
Close Price
₹30.78
Industry
Industry
Pharma - Formulators
PE
Price To Earnings
—
PS
Price To Sales
4.28
Revenue
Revenue
₹25Cr
Rev Gr TTM
Revenue Growth TTM
18.52%
PAT Gr TTM
PAT Growth TTM
71.22%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
006555579574
Growth YoY
Revenue Growth YoY%
23,450.0-17.940.864.315.350.5-38.1
Expenses
ExpensesCr
121188891214885
Operating Profit
Operating ProfitCr
-1-2-6-3-2-3-4-5-5-30-1
OPM
OPM%
-12,200.0-96.0-71.9-46.0-61.1-82.0-80.6-61.7-46.0-4.7-18.0
Other Income
Other IncomeCr
010000003004
Interest Expense
Interest ExpenseCr
001000111111
Depreciation
DepreciationCr
001111110000
PBT
PBTCr
-1-2-7-4-3-4-5-7-4-4-12
Tax
TaxCr
-1-1-1-1-1-1-1-2-1-101
PAT
PATCr
-1-1-6-3-2-3-5-5-3-3-12
Growth YoY
PAT Growth YoY%
9.1-62.0-2.8-140.0-354.0-161.724.2-69.2-12.812.077.5135.4
NPM
NPM%
-5,750.0-109.0-66.0-43.3-63.9-100.6-79.3-29.7-48.8-15.045.4
EPS
EPS₹
-0.2-0.5-2.8-0.8-0.7-0.6-1.1-1.4-0.7-0.7-0.50.6
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
006555579574
Growth YoY
Revenue Growth YoY%
23,450.0-17.940.864.315.350.5-38.1
Expenses
ExpensesCr
121188891214885
Operating Profit
Operating ProfitCr
-1-2-6-3-2-3-4-5-5-30-1
OPM
OPM%
-12,200.0-96.0-71.9-46.0-61.1-82.0-80.6-61.7-46.0-4.7-18.0
Other Income
Other IncomeCr
010000003004
Interest Expense
Interest ExpenseCr
001000111111
Depreciation
DepreciationCr
001111110000
PBT
PBTCr
-1-2-7-4-3-4-5-7-4-4-12
Tax
TaxCr
-1-1-1-1-1-1-1-2-1-101
PAT
PATCr
-1-1-6-3-2-3-5-5-3-3-12
Growth YoY
PAT Growth YoY%
9.1-62.0-2.8-140.0-354.0-161.724.2-69.2-12.812.077.5135.4
NPM
NPM%
-5,750.0-109.0-66.0-43.3-63.9-100.6-79.3-29.7-48.8-15.045.4
EPS
EPS₹
-0.2-0.5-2.8-0.8-0.7-0.6-1.1-1.4-0.7-0.7-0.50.6

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
4015192825
Growth
Revenue Growth%
-100.028.743.418.5
Expenses
ExpensesCr
41028324134
Operating Profit
Operating ProfitCr
0-10-12-13-14-9
OPM
OPM%
3.5-82.0-65.6-48.5-35.1
Other Income
Other IncomeCr
000037
Interest Expense
Interest ExpenseCr
002233
Depreciation
DepreciationCr
002222
PBT
PBTCr
0-10-16-17-16-7
Tax
TaxCr
0-2-4-4-5-2
PAT
PATCr
0-8-12-14-12-4
Growth
PAT Growth%
-5,305.7-56.7-14.014.371.2
NPM
NPM%
3.7-78.4-69.4-41.5-17.4
EPS
EPS₹
0.1-5.8-3.6-3.0-3.3-1.3
Financial YearMar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
4015192825
Growth
Revenue Growth%
-100.028.743.418.5
Expenses
ExpensesCr
41028324134
Operating Profit
Operating ProfitCr
0-10-12-13-14-9
OPM
OPM%
3.5-82.0-65.6-48.5-35.1
Other Income
Other IncomeCr
000037
Interest Expense
Interest ExpenseCr
002233
Depreciation
DepreciationCr
002222
PBT
PBTCr
0-10-16-17-16-7
Tax
TaxCr
0-2-4-4-5-2
PAT
PATCr
0-8-12-14-12-4
Growth
PAT Growth%
-5,305.7-56.7-14.014.371.2
NPM
NPM%
3.7-78.4-69.4-41.5-17.4
EPS
EPS₹
0.1-5.8-3.6-3.0-3.3-1.3

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
1021353535
Reserves
ReservesCr
-21372412
Current Liabilities
Current LiabilitiesCr
22122924
Non Current Liabilities
Non Current LiabilitiesCr
0093616
Total Liabilities
Total LiabilitiesCr
11259112087
Current Assets
Current AssetsCr
318142111
Non Current Assets
Non Current AssetsCr
87789976
Total Assets
Total AssetsCr
11259112087
Financial YearMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
1021353535
Reserves
ReservesCr
-21372412
Current Liabilities
Current LiabilitiesCr
22122924
Non Current Liabilities
Non Current LiabilitiesCr
0093616
Total Liabilities
Total LiabilitiesCr
11259112087
Current Assets
Current AssetsCr
318142111
Non Current Assets
Non Current AssetsCr
87789976
Total Assets
Total AssetsCr
11259112087

Cash Flow

Consolidated
Standalone
Financial YearMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
0-4-11-15-4
Investing Cash Flow
Investing Cash FlowCr
0-5-75-1223
Financing Cash Flow
Financing Cash FlowCr
0217823-20
Net Cash Flow
Net Cash FlowCr
012-8-4-1
Free Cash Flow
Free Cash FlowCr
0-6-33-2711
CFO To PAT
CFO To PAT%
-178.753.289.7111.935.1
CFO To EBITDA
CFO To EBITDA%
-189.240.785.7118.530.0
Financial YearMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
0-4-11-15-4
Investing Cash Flow
Investing Cash FlowCr
0-5-75-1223
Financing Cash Flow
Financing Cash FlowCr
0217823-20
Net Cash Flow
Net Cash FlowCr
012-8-4-1
Free Cash Flow
Free Cash FlowCr
0-6-33-2711
CFO To PAT
CFO To PAT%
-178.753.289.7111.935.1
CFO To EBITDA
CFO To EBITDA%
-189.240.785.7118.530.0

Ratios

Consolidated
Standalone
Financial YearMar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
134718324298109
Price To Earnings
Price To Earnings
89.4
Price To Sales
Price To Sales
3.312.112.43.54.3
Price To Book
Price To Book
1.52.12.54.12.02.3
EV To EBITDA
EV To EBITDA
91.1-3.5-15.1-22.0-8.9-14.4
Profitability Ratios
Profitability Ratios
GPM
GPM%
9.39.422.330.130.1
OPM
OPM%
3.5-82.0-65.6-48.5-35.1
NPM
NPM%
3.7-78.4-69.4-41.5-17.4
ROCE
ROCE%
1.6-44.8-17.4-15.5-18.0-18.0
ROE
ROE%
1.7-34.2-16.4-22.8-24.3-24.3
ROA
ROA%
1.3-30.7-13.0-11.3-13.3-13.3
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
134718324298109
Price To Earnings
Price To Earnings
89.4
Price To Sales
Price To Sales
3.312.112.43.54.3
Price To Book
Price To Book
1.52.12.54.12.02.3
EV To EBITDA
EV To EBITDA
91.1-3.5-15.1-22.0-8.9-14.4
Profitability Ratios
Profitability Ratios
GPM
GPM%
9.39.422.330.130.1
OPM
OPM%
3.5-82.0-65.6-48.5-35.1
NPM
NPM%
3.7-78.4-69.4-41.5-17.4
ROCE
ROCE%
1.6-44.8-17.4-15.5-18.0-18.0
ROE
ROE%
1.7-34.2-16.4-22.8-24.3-24.3
ROA
ROA%
1.3-30.7-13.0-11.3-13.3-13.3
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios

Documents — Pharmaids Pharmaceuticals Ltd

  • Q1 FY2027 Quarterly Result (Jun 2026, PDF): https://www.stockscans.in/document/1op7512daigy3zl3y9b7wvv4.pdf
  • Q4 FY2026 Quarterly Result (Mar 2026, PDF): https://www.stockscans.in/document/yeriwdk8iakxzpf7ggrcbt4q.pdf
  • Q3 FY2026 Quarterly Result (Dec 2025, PDF): https://www.stockscans.in/document/j5rzf20lrk17r3qbwyf8ialh.pdf
  • Q2 FY2026 Quarterly Result (Sep 2025, PDF): https://www.stockscans.in/document/areta44omdqykxpov2y1o3py.pdf
  • Q4 FY2025 Quarterly Result (Mar 2025, PDF): https://www.stockscans.in/document/kxzjw4mg7x9l3wudsu0tyiky.pdf
  • Q3 FY2025 Quarterly Result (Dec 2024, PDF): https://www.stockscans.in/document/dd1e0owejl0vw5jipq855g2x.pdf
  • Q2 FY2025 Quarterly Result (Sep 2024, PDF): https://www.stockscans.in/document/k25y5elj9veo1k0dy08l3h9d.pdf
  • Q1 FY2025 Quarterly Result (Jun 2024, PDF): https://www.stockscans.in/document/gab7o0rbgemg3joujeqydadk.pdf
  • FY2026 Annual Report (PDF): https://www.stockscans.in/document/o2pvasclm9drs0zxv363p91a.pdf
  • FY2025 Annual Report (PDF): https://www.stockscans.in/document/dvoybrwj53rhosgkoi8eagdc.pdf
  • FY2024 Annual Report (PDF): https://www.stockscans.in/document/kn3u3t0zudmvsv20wktv30al.pdf
  • FY2023 Annual Report (PDF): https://www.stockscans.in/document/gs6dy6hmxqdz7413n1y8dxxf.pdf
  • FY2022 Annual Report (PDF): https://www.stockscans.in/document/nvta9zzwxhf3jau50nh1lvqx.pdf
  • FY2021 Annual Report (PDF): https://www.stockscans.in/document/5x02rypje9j5bz215j8wi3s7.pdf
  • FY2020 Annual Report (PDF): https://www.stockscans.in/document/y4w16p0nd5lnmeq41hy9v6yf.pdf

Simplify stock analysis with powerful tools and clear insights for confident, data-driven decisions.

support@stockscans.in
© StockScans by SOIC Technologies Pvt Ltd
349 A, Lodhi Road, Punjabi Bazar, New DelhiData provided by CMOTS Internet Technologies